Erasca Inc
Erasca Inc (ERAS) Option Chain
As of September 21, 2026, Erasca Inc is trading at $15.55, a +3.40% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 91.3%. IV Rank is 11%.
Read more
Tracking the ERAS option chain helps you see every strike and expiry on Erasca Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Erasca Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ERAS options activity at a glance. Use our scanner to monitor the ERAS option chain in real time and filter for the ERAS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ERAS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ERAS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ERAS stock options are being actively traded and where they are not.
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Erasca Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ERAS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ERAS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile46.43% Neutral
- Market cap (M$)5,439
- 52 weeks high-35.96%
- 52 weeks low788.57%
- Analyst recommendationStrong Buy
1.40 - Target price$23.70
52.41% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-0.95
- EPS growth next 5 years-20.83%
As of September 21, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 6.90 | 251 | 1 | -0.20 | 5.55 | 5.00 | 5.70 | 10.00 | -33.51 | — | 0.55 | 0.00 | 0.55 | 0 | 1,584 | 93.10 |
| 27.15 | 438 | 5 | 0.50 | 3.05 | 2.80 | 4.30 | 12.50 | -16.89 | 0.20 | 0.60 | 0.00 | 0.40 | 26 | 551 | 72.85 |
| 54.24 | 14,978 | 1,165 | 0.97 | 0.55 | 1.35 | 1.70 | 15.00 | -0.27 | 1.00 | 1.95 | 0.00 | 1.48 | 17 | 1,337 | 45.76 |
| 76.15 | 1,698 | 176 | 0.58 | 0.00 | 0.40 | 0.75 | 17.50 | +16.36 | 2.65 | 3.40 | 1.95 | 1.08 | 1 | 320 | 23.85 |
| 89.15 | 8,996 | 36 | 0.40 | 0.00 | 0.15 | 0.65 | 20.00 | +32.98 | 4.80 | 5.50 | 4.45 | 0.70 | 0 | 1,341 | 10.85 |
As of September 21, 2026
Scan the full option chain in one place
Browse the full ERAS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→